Commonwealth Equity Services
ONCY

Commonwealth Equity Services’s Oncolytics Biotech ONCY Stock Holding History

Commonwealth Equity Services’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4K Hold
35,114
– – ﹤0.01% 4329
2026
Q1 		$29.8K Hold
35,114
– – ﹤0.01% 4235
2025
Q4 		$30.7K Buy
35,114
+10,000
+40% +$10.8K ﹤0.01% 4217
2025
Q3 		$35K Sell
25,114
-40,000
-61% -$44.8K ﹤0.01% 4182
2025
Q2 		$50K Buy
65,114
+4,000
+7% +$2.12K ﹤0.01% 4154
2025
Q1 		$34K Buy
61,114
+1,000
+2% +$731 ﹤0.01% 4097
2024
Q4 		$55K Sell
60,114
-1,000
-2% -$1.04K ﹤0.01% 3976
2024
Q3 		$53K Sell
61,114
-2,000
-3% -$1.96K ﹤0.01% 3931
2024
Q2 		$62K Buy
63,114
+350
+0.6% +$381 ﹤0.01% 3873
2024
Q1 		$67K Buy
62,764
+7,184
+13% +$8.03K ﹤0.01% 3855
2023
Q4 		$75K Buy
+55,580
New +$86.9K ﹤0.01% 3711

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Commonwealth Equity Services's ONCY Position: Q2 2026 in Review

Commonwealth Equity Services held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 35,114 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4329.

Commonwealth Equity Services first reported a position in ONCY in Q4 2023 and has held it in 11 quarters since. The position peaked at $75K in Q4 2023. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Commonwealth Equity Services held 35,114 shares of Oncolytics Biotech worth $33.4K as of Q2 2026.
  • Commonwealth Equity Services left its Oncolytics Biotech share count unchanged in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4329 holding.
  • Commonwealth Equity Services first reported a position in Oncolytics Biotech in Q4 2023 and has held it in 11 quarters since.
  • Commonwealth Equity Services's Oncolytics Biotech position peaked at $75K in Q4 2023.
  • 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.